These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2653512

  • 21. Influence of radiation field and fractionation schedule of total lymphoid irradiation (TLI) on the induction of suppressor cells and stable chimerism after bone marrow transplantation in mice.
    Waer M, Ang KK, Van der Schueren E, Vandeputte M.
    J Immunol; 1984 Feb; 132(2):985-90. PubMed ID: 6228603
    [Abstract] [Full Text] [Related]

  • 22. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL, Zadach K, Nalesnik M, Ildstad ST.
    Transplantation; 1995 Nov 15; 60(9):971-80. PubMed ID: 7491703
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
    Azuma E, Yamamoto H, Kaplan J.
    J Immunol; 1989 Sep 01; 143(5):1524-9. PubMed ID: 2668409
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evaluation of chimerism after bone marrow transplantation with single locus minisatellite DNA probes.
    Harano H, Maruta A, Matsuzaki M, Kanamori H, Fukawa H, Noguchi T, Miyashita H, Ogawa K, Motomura S, Kodama F.
    Bone Marrow Transplant; 1993 Sep 01; 12(3):221-4. PubMed ID: 8241980
    [Abstract] [Full Text] [Related]

  • 30. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM, Gorechlad J, Larsen CP, Waller EK.
    Biol Blood Marrow Transplant; 2006 Dec 01; 12(12):1239-49. PubMed ID: 17162205
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study.
    Choi SJ, Lee KH, Lee JH, Kim S, Chung HJ, Lee JS, Kim SH, Park CJ, Chi HS, Kim WK.
    Bone Marrow Transplant; 2000 Aug 01; 26(3):327-32. PubMed ID: 10967574
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD, Drobyski WR, Truitt RL.
    Bone Marrow Transplant; 1993 Apr 01; 11(4):329-36. PubMed ID: 8485480
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Allogeneic hematopoietic transplantation and leukemia: a second chance for T cells?
    Kuppen PJ.
    Transplantation; 2008 Jan 15; 85(1):7-8. PubMed ID: 18192904
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacological bone marrow purging with drugs other than cyclophosphamide derivatives.
    Douay L.
    Bone Marrow Transplant; 1989 Jan 15; 4 Suppl 1():195. PubMed ID: 2469509
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.